What is a stock summary page? Click here for an overview.
Business Description
Cadrenal Therapeutics Inc
NAICS : 541713
SIC : 2833
ISIN : US1276361086
Description
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5009 | |||||
| Equity-to-Asset | 0.74 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | 32.98 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.78 | |||||
| 9-Day RSI | 20.46 | |||||
| 14-Day RSI | 29.62 | |||||
| 3-1 Month Momentum % | 1.81 | |||||
| 6-1 Month Momentum % | 36.11 | |||||
| 12-1 Month Momentum % | 120.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.77 | |||||
| Quick Ratio | 3.77 | |||||
| Cash Ratio | 3.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -16.85 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -185.38 | |||||
| ROA % | -148.64 | |||||
| ROIC % | -1857.8 | |||||
| ROC (Joel Greenblatt) % | -88758.33 | |||||
| ROCE % | -185.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.5 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| EV-to-EBIT | -2.19 | |||||
| EV-to-Forward-EBIT | -2.01 | |||||
| EV-to-EBITDA | -2.19 | |||||
| EV-to-Forward-EBITDA | -2.01 | |||||
| EV-to-FCF | -3.54 | |||||
| Price-to-Net-Current-Asset-Value | 3.51 | |||||
| Price-to-Net-Cash | 3.55 | |||||
| Earnings Yield (Greenblatt) % | -45.66 | |||||
| FCF Yield % | -26.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CVKD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cadrenal Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -8.67 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 97.41 | ||
| 14-Day RSI | 29.62 | ||
| 14-Day ATR ($) | 1.545168 | ||
| 20-Day SMA ($) | 18.1795 | ||
| 12-1 Month Momentum % | 120.26 | ||
| 52-Week Range ($) | 5.399999 - 22.9011 | ||
| Shares Outstanding (Mil) | 1.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cadrenal Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cadrenal Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cadrenal Therapeutics Inc Frequently Asked Questions
What is Cadrenal Therapeutics Inc(CVKD)'s stock price today?
The current price of CVKD is $14.63. The 52 week high of CVKD is $22.90 and 52 week low is $5.40.
When is next earnings date of Cadrenal Therapeutics Inc(CVKD)?
The next earnings date of Cadrenal Therapeutics Inc(CVKD) is 2025-05-30 Est..
Does Cadrenal Therapeutics Inc(CVKD) pay dividends? If so, how much?
Cadrenal Therapeutics Inc(CVKD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers